Search

Prudent audiology

Introduction In January 2014, Professor Mark Drakeford, Minister for Health and Social Services, defined Prudent Healthcare as, “Healthcare that fits the needs and circumstances of patients and actively avoids wasteful care that is not to the patient’s benefit.” ‘Prudent’ healthcare...

Leadership challenges in the world 
of AQP and accreditation – learning from experience

The words ‘choice and competition’, ‘any qualified provider (AQP)’ and ‘accreditation’ have irrevocably become part of audiology jargon in the last two years in England. Commissioners who chose ‘Adult Hearing Aid Services for age-related hearing loss’ have begun the process...

Scientific advances in mapping syndromic hearing loss

From more than 22000 genes that we humans have, approximately 3000 genes are associated with human communication. There are tens of syndromes which have been identified to be accompanied by hearing loss. Disorders of almost every organ of the body...

Music and single-sided deafness: challenges and solutions

Music is an integral part of many of our lives, providing entertainment, relaxation and a backing track to our past experiences. In this overview, Gemma Crundwell and David Baguley examine the impact of SSD on the perception of music and...

Using psychological behaviour change theory in vestibular practice

Fiona Barker explains the importance of recognising and understanding how habitual behaviours in vestibular patients can affect treatment outcomes, and how we as audiologists can support and encourage patients to modify these behaviours and perhaps address our own professional behaviours...

The European TINNET COST Action BM1306

Winfried Schlee describes how a major European funding award is bringing together experts who are committed to collectively developing a better understanding of tinnitus. This work is vital if we are to pioneer effective treatments for the condition in its...

Outcome measurements WG5. Developing a core outcome set of measures for tinnitus

Alain Londero presents a large-scale collaboration that invites clinicians and patients to develop a minimum standard for assessing the efficacy of tinnitus treatments. This will become an international recommendation for all clinical trials of tinnitus. WG5 is working towards a...

How entrepreneurs can integrate hearables into their clinic

Brian Taylor provides an interesting perspective on market segmentation of the hearing impaired population, and how as clinicians and entrepreneurs we need to be able to recognise the different approaches that are required to address the large percentage of the...

What’s new in implantable devices? New indications in cochlear implantation

For over 40 years, cochlear implant procedures have steadily increased. Outcomes for patients are improving as a result of modified surgical techniques, a wider portfolio of electrode arrays, advances in programming strategies, access to improved technology and a better understanding...

A place for everything and everything in its place: the practicalities of randomised clinical trials

Will this pill cure tinnitus? Bonnie Millar describes one trial that has investigated the possibility whilst describing the path of drug trials in the UK. Background In the last quarter of 2014, a clinical trial (QUIET-1; ClinicalTrials.gov Identifier: NCT02315508) commenced...

The role of public health in addressing age-related hearing loss

Prevention and treatment of hearing loss needs to be viewed through a public health lens, but what does that look like? Kelly Reavis and colleagues explain the steps to addressing hearing healthcare from a public health perspective and why this...

Infant hearing loss impacts spoken language development: identify and intervene early

Early hearing detection and intervention programmes have been implemented in many countries across the globe, but why are these programmes so important and how are our Canadian colleagues managing this process? The consequences of being born with a permanent hearing...